US ▾
LFVN
Earnings call · Jun 2026 (Q4 FY26)

Lifevantage Q4 FY26 earnings call LFVN

Aug 27, 2026 Source

Executive summary

LifeVantage Q4 FY26 — New CEO Outlines Strategic Priorities Amid Revenue Decline

New CEO Terrence Moorehead outlined three strategic priorities: strengthening the brand, building a more relevant consumer proposition, and improving operational excellence, following a quarter marked by significant revenue decline. The company maintains a strong balance sheet and capital allocation strategy but is not issuing formal guidance during this transition period, focusing instead on a comprehensive strategic review.

Highlights

5

  • Gross profit percentage remained strong at 78% in Q4 FY26.

  • Subscription-based revenue represented more than 75% of total revenue in Q4 FY26.

  • Customer retention metrics improved year over year.

  • Maintained a strong financial position with $14.9 million in cash and no debt at fiscal year-end 2026.

  • Generated $10.2 million in cash from operations during fiscal 2026.

Concerns

5

  • Net revenue decreased 23.1% to $42.4 million in Q4 FY26 compared to $55.1 million in Q4 FY25.

  • Revenue decreased 3.1% sequentially from Q3 FY26 to Q4 FY26.

  • Gross profit percentage declined to 78% from 79.9% in the prior year period.

  • Adjusted EBITDA decreased to $2.7 million (6.5% of revenue) in Q4 FY26 from $4.8 million (8.7% of revenue) in Q4 FY25.

  • Adjusted non-GAAP net income decreased to $1.4 million ($0.11 per diluted share) from $2.3 million ($0.17 per diluted share) in Q4 FY25.

Segment performance

SegmentRevenueYoYQoQMargin
Americas
Revenue decreased primarily due to downward pressure in orders and lower average order size, impacted by the broader macroeconomic environment.
$32.7 million-24.8%——
Asia-Pacific and Europe
Revenue decreased, reflecting impacts from the broader macroeconomic environment and lower sales of the MindBody GLP-1 System.
$9.7 million-16.9%——

Deals & partnerships

LoveBiome Acquisition of LoveBiome

Acquired in October 2025, partially offsetting the Q4 FY26 revenue decline. The transaction utilized $3.7 million in cash during fiscal 2026.

Capital programs

Shopify integration underway
Period spend: $3.6 million

Benefit:upgrading our e-commerce platform

Capital expenditures totaled $3.6 million in fiscal 2026, reflecting continued investment in technology infrastructure, including the Shopify integration. The company anticipates spending $3 million to $3.5 million in FY27 to close out the final stages.

Risks & headwinds

Downward pressure on orders and average order size Q4 FY26, ongoing

Net revenue down 23.1% YoY to $42.4 million in Q4 FY26; down 3.1% sequentially.

Mitigation:Strengthening value proposition, attracting new customers, implementing new strategies in FY27.

Broader macroeconomic environment impact Q4 FY26, ongoing

Contributed to downward pressure on orders and average order size, impacting revenue.

Mitigation:Strengthening value proposition, attracting new customers, implementing new strategies in FY27.

Lower sales of MindBody GLP-1 System Q4 FY26

Contributed to revenue decline in Q4 FY26, cycling higher comparable Q4 FY25.

Mitigation:Focus on strengthening brand and consumer proposition for overall portfolio.

Gross margin pressure from product mix, inventory obsolescence, and shipping costs Q4 FY26

Gross profit percentage declined to 78% in Q4 FY26 from 79.9% in Q4 FY25.

Mitigation:Improving operational excellence and profitability.

Difficult revenue comparables for early fiscal 2027 Q1 FY27, Q2 FY27

Expected to face difficult comparables in Q1 and Q2 of fiscal year 2027.

Mitigation:Implementing new strategies, with anticipated trend reversal and momentum from Q3 FY27 onwards.

What to watch in Q1 FY27

Revenue trend stabilization and improvement

Q1 FY27, Q2 FY27 (for stabilization), Q3 FY27 (for momentum)
Current Down 23.1% YoY in Q4 FY26; down 3.1% QoQ.
Target Stabilization, then momentum from Q3 FY27.

Why it matters

Indicates effectiveness of new CEO's strategic initiatives and potential for business turnaround.

When we get to our fiscal Q3 into Q4, that's really where we anticipate that we hopefully can turn the trend line and really start to see a little bit of momentum associated with those strategies that we're working on and look to be putting in place at the first part of the year.

Q&A highlights

Inquired about sequential revenue decline, monthly trends in Q4, and early Q1 (July/August) trends, asking if stabilization or improvement has been observed.

Carl Oury confirmed sequential decline due to fewer orders and lower average order size. He noted difficult comparables for Q1 and Q2 FY27, expecting potential trend reversal and momentum from Q3 FY27 onwards as new strategies are implemented.

“When we get to our fiscal Q3 into Q4, that's really where we anticipate that we hopefully can turn the trend line and really start to see a little bit of momentum associated with those strategies that we're working on and look to be putting in place at the first part of the year.”

asked by Ryan Meyers · answered by Carl Oury

2 min read 6 chapters

Detailed narrative

New CEO's Vision and Priorities

Terrence Moorehead, the new CEO, expressed strong conviction in LifeVantage's differentiated science, solid balance sheet, and untapped potential. His initial focus will be on three priorities: strengthening the LifeVantage brand, building a more relevant consumer proposition, and improving operational excellence and profitability. He aims to unlock the company's potential by reimagining key aspects of the business.

Strategic Review and Future Outlook

Moorehead emphasized that it's early in his tenure, and the company will not provide formal guidance at this time. Over the next several months, the leadership team will develop a comprehensive growth strategy with clear priorities and measurable objectives. He believes the company has far greater potential than its current scale reflects and is confident in creating long-term value for stakeholders.

Revenue Performance and Drivers

Net revenue for Q4 FY26 was $42.4 million, down 23.1% year-over-year, and down 3.1% sequentially from Q3 FY26. The decline was attributed to downward pressure in the number of orders from the active account base, lower average order size, macroeconomic impacts, and lower sales of the MindBody GLP-1 System, partially offset by sales from the LoveBiome acquisition.

Geographic Performance and International Strategy

Revenue in the Americas region decreased 24.8% to $32.7 million, while Asia-Pacific and Europe revenue decreased 16.9% to $9.7 million. The CEO sees international markets as an opportunity but plans to drive penetration in existing markets rather than immediate expansion, adopting a 'hub and spoke' approach.

Digital Transformation and Consumer Focus

The company is undertaking a program to upgrade its website and consumer experience, alongside enhancing digital tools for its sales force to improve go-to-market effectiveness. The CEO highlighted the importance of becoming a more consumer-centric company and improving digital capabilities to increase demand across all fronts.

Financial Strength and Capital Allocation

LifeVantage maintains a strong financial position with $14.9 million in cash and no debt, and access to a $5 million revolving line of credit. The company generated $10.2 million in cash from operations in FY26. It continues its balanced capital allocation strategy, including share repurchases ($2.0 million in FY26) and quarterly cash dividends ($0.05 per share).

AI-generated summary of the company's earnings call. Not investment advice.